Precision Medicine Treatment: Gene-Targeting Mesothelioma
| |

Precision Medicine Treatment: Gene-Targeting Mesothelioma

A new precision medicine treatment for mesothelioma comes from scientists in Italy. This form of mesothelioma occurs after asbestos exposure in people with a genetic mutation. The mutation is represented by patients with an inherited cancer syndrome. These patients typically have an even worse prognosis than other mesothelioma patients. But the Italian team came up with a way to target the mutated gene. This form of treatment is called precision medicine. Precision medicine treatment looks at the genetics of a patient to select a treatment that will work best for them. Discovery of a DNA Gene Mutation Malignant pleural mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. Malignant mesothelioma is one of the most aggressive kinds…

Faulty DNA Repair Genes May Raise Mesothelioma Risk
|

Faulty DNA Repair Genes May Raise Mesothelioma Risk

Not everyone who is exposed to asbestos has the same risk of developing mesothelioma.  Now, new research supports the idea that some people’s genetic inability to repair DNA damage at the cellular level may raise their risk of mesothelioma. When asbestos dust is inhaled, tiny fibers can lodge in the lungs and stay there for decades, causing irritation and inflammation that have been linked to a range of illnesses, including asbestosis, lung cancer and malignant mesothelioma. But scientists have not been able to come up with a specific genetic explanation for why different people exposed to the same amount of asbestos dust do not contract these diseases at the same rate. Now, a group of Italian researchers believe they may have found…